PERRIGO Co plc — Director's Dealing 2021

Mar 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PERRIGO Co plc (PRGO)
CIK: 0001585364
Period of Report: 2021-03-05

Reporting Person: Quinn Grainne (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-08	Ordinary Shares	A	2082	$41.82	Acquired	6741	Direct
2021-03-08	Ordinary Shares	F	1083	$41.82	Disposed	5658	Direct
2021-03-05	Ordinary Shares	M	1226	$41.04	Acquired	6884	Direct
2021-03-05	Ordinary Shares	F	638	$41.04	Disposed	6246	Direct
2021-03-05	Ordinary Shares	M	1053	$41.04	Acquired	7299	Direct
2021-03-05	Ordinary Shares	F	548	$41.04	Disposed	6751	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-05	Restricted Stock Units	$	A	4751	Acquired		Ordinary Shares (4751.0)	Direct

Footnotes

F1: Vesting of performance-based restricted stock units granted on March 8, 2018.

F2: Vesting of service-based restricted stock units granted on March 6, 2019.

F3: Vesting of service-based restricted stock units granted on March 5, 2020.

F4: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F5: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.